Interleukin-secreting natural killer cell lines and methods of use
View Patent ↗This invention relates to a natural killer cell line termed NK-92 and to NK-92 cell lines that have been modified by transfection with a vector to confer advantageous properties. The invention provides a modified NK-92 cell line that is transfected with a vector encoding a cytokine that promotes the growth of NK-92 cells. In a significant embodiment, the cytokine is interleukin 2. The invention additionally provides a modified NK-92 cell line that is transfected with a vector that expresses a thymidine kinase gene. The invention further provides a modified NK-92 cell line that is transfected with a vector that expresses a β 2 micrglobulin.
1. A modified NK-92 cell, said modified NK-92 cell comprising an NK-92 cell line ATCC Deposit No. PTA-6672.